Mesoblast
MESO
#4330
Rank
NZ$4.17 B
Marketcap
NZ$32.44
Share price
3.59%
Change (1 day)
75.35%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$0.32 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are NZ$0.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30NZ$0.30 B13.3%
2023-06-30NZ$0.27 B3.27%
2022-06-30NZ$0.26 B13.34%
2021-06-30NZ$0.23 B-18.28%
2020-06-30NZ$0.28 B12.27%
2019-06-30NZ$0.25 B17.67%
2018-06-30NZ$0.21 B13.96%
2017-06-30NZ$0.18 B-13.12%
2016-06-30NZ$0.21 B-52.76%
2015-06-30NZ$0.46 B23.66%
2014-06-30NZ$0.37 B14.13%
2013-06-30NZ$0.32 B8.8%
2012-06-30NZ$0.30 B0.8%
2011-06-30NZ$0.29 B12848.29%
2010-06-30NZ$2.3 M24.79%
2009-06-30NZ$1.84 M-10.59%
2008-06-30NZ$2.06 M127.4%
2007-06-30NZ$0.9 M-87.72%
2006-06-30NZ$7.4 M129.78%
2005-06-30NZ$3.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
NZ$0.20 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ$5.44 M-98.32% Bahamas